Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between JCV large T-antigen and beta-catenin.

Dai-Di Gan1, Kamel Khalili

  • 1Center for Neurovirology and Cancer Biology, Temple University, 1900 North 12th Street, 015-96, Room 203, Philadelphia, PA 19122, USA.

Oncogene
|January 16, 2004
PubMed
Summary

The John Cunningham virus (JCV) T-antigen interacts with beta-catenin, stabilizing it and promoting its nuclear entry. This interaction activates Wnt signaling, contributing to cerebellar tumor development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CRISPR antiviral inhibits neurotrophic JC polyomavirus in 2D and 3D culture models through dual-gRNA excision by SaCas9.

Molecular therapy. Nucleic acids·2025
Same author

Neurotropic Viruses as Acute and Insidious Drivers of Aging.

Biomolecules·2025
Same author

CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model.

Molecular therapy. Methods & clinical development·2024
Same author

Suppression of HSV-1 infection and viral reactivation by CRISPR-Cas9 gene editing in 2D and 3D culture models.

Molecular therapy. Nucleic acids·2024
Same author

HIV-1 mRNA knockdown with CRISPR/CAS9 enhances neurocognitive function.

Journal of neurovirology·2024
Same author

Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates.

Gene therapy·2024

Area of Science:

  • Neuro-oncology
  • Viral oncology
  • Molecular biology

Background:

  • John Cunningham virus (JCV) T-antigen expression causes cerebellar tumors in mice.
  • JCV is associated with human primitive neuroectodermal tumors (PNETs).
  • The Wnt signaling pathway is implicated in cerebellar tumor development.

Purpose of the Study:

  • To investigate the interaction between JCV T-antigen and beta-catenin, a key Wnt pathway protein.
  • To elucidate the mechanism by which T-antigen influences beta-catenin activity.
  • To identify a novel oncogenic pathway for JCV T-antigen.

Main Methods:

  • Investigated physical interaction between T-antigen and beta-catenin using specific protein domains.
  • Assessed beta-catenin levels and cellular localization in the presence of T-antigen.

Related Experiment Videos

  • Measured downstream target gene promoter activity (e.g., c-myc) upon T-antigen and beta-catenin coexpression.

    • Main Results:

    • Demonstrated direct physical interaction between JCV T-antigen (residues 82-628) and beta-catenin (residues 695-781).
    • T-antigen binding increases beta-catenin stability and promotes its nuclear translocation.
    • Coexpression of T-antigen and beta-catenin enhances transcription of Wnt-dependent promoters, including c-myc.

    Conclusions:

    • JCV T-antigen physically interacts with beta-catenin, stabilizing it and facilitating its nuclear import.
    • This interaction represents a novel oncogenic pathway for JCV, contributing to tumor formation.
    • JCV T-antigen can deregulate the Wnt pathway by stabilizing beta-catenin, offering a new mechanism for viral oncogenesis.